ASHTEN EMBRY: Open Payments
NPI 1144092131 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,394 in 122 payments from 18 companies in 2025. Trend: 2023 $208 · 2024 $2,565 · 2025 $2,394
Food & beverage: $2,394
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $606 |
| Phathom Pharmaceuticals, Inc. | 12 | $258 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $243 |
| Janssen Biotech, Inc. | 10 | $186 |
| Ardelyx, Inc. | 7 | $164 |
| GENZYME CORPORATION | 4 | $117 |
| Madrigal Pharmaceuticals | 5 | $115 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $110 |
| Gilead Sciences, Inc. | 5 | $108 |
| Regeneron Healthcare Solutions, Inc. | 4 | $98 |
Products named: TREMFYA, RINVOQ, VOQUEZNA, DUPIXENT, ENTYVIO, LINZESS, IBSRELA, REZDIFFRA.
Industry payments across KY — which companies pay providers there.
